Author: Rauf, Abdur; Abu-Izneid, Tareq; Olatunde, Ahmed; Ahmed Khalil, Anees; Alhumaydhi, Fahad A.; Tufail, Tabussam; Shariati, Mohammad Ali; Rebezov, Maksim; Almarhoon, Zainab M.; Mabkhot, Yahia N.; Alsayari, Abdulrhman; Rengasamy, Kannan R. R.
Title: COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies Cord-id: w3lhkzjt Document date: 2020_11_4
ID: w3lhkzjt
Snippet: Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronavirus. Interestingly, the virus binds with angiotensin-converting enzyme-2 found in host cells, through the spike (S) protein that exists on its surface. This binding causes the entry of the virus into ce
Document: Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronavirus. Interestingly, the virus binds with angiotensin-converting enzyme-2 found in host cells, through the spike (S) protein that exists on its surface. This binding causes the entry of the virus into cells of the host organism. The actual mechanism used by the COVID-19 virus to induce disease is still speculative. A total of 44,322,504 cases, a 1,173,189 death toll and 32,486,703 recovery cases have been reported in 217 countries globally as of 28 October 2020. Symptoms from the infection of the virus include chest pain, fever, fatigue, nausea, and others. Acute respiratory stress syndrome, arrhythmia, and shock are some of the chronic manifestations recorded in severe COVID-19. Transmission is majorly by individual-to-individual through coughing, sneezing, etc. The lack of knowledge regarding the mechanism of and immune response to the virus has posed a challenge in the development of a novel drug and vaccine. Currently, treatment of the disease involves the use of anti-viral medications such as lopinavir, remdesivir, and other drugs. These drugs show some efficacy in the management of COVID-19. Studies are still on-going for the development of an ideal and novel drug for treatment. In terms of natural product intervention, Traditional Chinese Medicines (TCM) have been employed to alleviate the clinical manifestation and severity of the disease and have shown some efficacy. This review presents an updated detailed overview of COVID-19 and the virus, concerning its structure, epidemiology, symptoms and transmission, immune responses, and current interventions, and highlights the potential of TCM. It is anticipated that this review will further add to the understanding of COVID-19 and the virus, hence opening new research perspectives.
Search related documents:
Co phrase search for related documents- abdominal pain and acute kidney injury aki: 1, 2, 3, 4, 5, 6
- abdominal pain and acute myocardial injury: 1
- abdominal pain and acute pandemic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- accessory protein and acid inducible: 1
- accessory protein and acid inducible gene: 1
- accessory protein and activator kinase signal transducer: 1
- accessory protein and acute pandemic: 1, 2
- accidental infection and acute pandemic: 1
- acid inducible and activator kinase signal transducer: 1
- acid inducible and acute kidney injury: 1
- acid inducible gene and activator kinase signal transducer: 1
- acid inducible gene and acute kidney injury: 1
Co phrase search for related documents, hyperlinks ordered by date